These observations align with emerging evidence suggesting that CIITA-induced MHC-II expression on tumor cells facilitates the recruitment and priming of T cells within the tumor microenvironment, thereby augmenting immune surveillance and cytotoxic responses. This evidence concerns the gene CIITA and neoplasm.